Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.37 |
| ▸ | IL1R1 | P14778 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17123113 | 0.97 | L3MBTL1 (0.44) | L3MBTL1KDM4EATMKMT2AIL1R1 | |
| SCHEMBL20311804 | 0.95 | L3MBTL1 (0.40) | L3MBTL1KDM4EATMKMT2AIL1R1 | |
| SCHEMBL20390232 | 0.95 | L3MBTL1 (0.44) | L3MBTL1KDM4EATMKMT2AIL1R1 | |
| SCHEMBL17207322 | 0.95 | L3MBTL1 (0.40) | L3MBTL1KDM4EATMKMT2AIL1R1 | |
| SCHEMBL17123096 | 0.93 | L3MBTL1 (0.41) | L3MBTL1KDM4EATMKMT2AIL1R1 | |
| SCHEMBL17427664 | 0.93 | L3MBTL1 (0.41) | L3MBTL1KDM4EATMKMT2AIL1R1 | |
| SCHEMBL23741533 | 0.92 | L3MBTL1 (0.38) | L3MBTL1KDM4EATMKMT2AIL1R1 | |
| SCHEMBL19998002 | 0.92 | L3MBTL1 (0.42) | L3MBTL1KDM4EATMKMT2AIL1R1 | |
| SCHEMBL14900857 | 0.92 | L3MBTL1 (0.44) | L3MBTL1KDM4EATMKMT2AIL1R1 | |
| SCHEMBL19046741 | 0.92 | L3MBTL1 (0.36) | L3MBTL1KDM4EATMKMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9780314-B2 | Compound for organic electric element, organic electric element comprising the same and electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2017-10-03 | — | — | US | disclosed |
| US-9780314-B2 | Compound for organic electric element, organic electric element comprising the same and electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2017-10-03 | — | — | US | disclosed |
| US-20160020408-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2016-01-21 | — | — | US | disclosed |
| US-20160020408-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2016-01-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160020408-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF | OR51E2, NFE2L2, ORAI2 | L3MBTL1 942/4885KDM4E 446/4885ATM 2208/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.